Inventor · disambiguated record
Lawrence Friedhoff
Also filed as: FRIEDHOFF LAWRENCE · FRIEDHOFF LAWRENCE T · FRIEDHOFF LAWRENCE TIM
14 granted patents·46 pending applications·169 citations·filing 1988–2023
92Inventor score
Top patents by PatentIndex Score
60 records- 0196US9345711B2Methods for acute and long-term treatment of drug addictionDEMERX INC·Filed 2014·Granted May 24, 2016·39 cites·16 claims
- 0288US10034859B2Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative diseaseAXOVANT SCIENCES GMBH·Filed 2016·Granted Jul 31, 2018·4 cites·50 claims
- 0387US9561233B2Use of ibogaine for the treatment of painDEMERX INC·Filed 2015·Granted Feb 7, 2017·3 cites·6 claims
- 0484US11304932B2Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative diseaseAXOVANT SCIENCES GMBH·Filed 2020·Granted Apr 19, 2022·1 cites·28 claims
- 0584US10022355B2Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorderAXOVANT SCIENCES GMBH·Filed 2016·Granted Jul 17, 2018·5 cites·68 claims
- 0683US4925873AMethod of treating skin injuries using thromboxane A2 receptor antagonistsSQUIBB & SONS INC·Filed 1988·Granted May 15, 1990·35 cites·14 claims
- 0782US2024390384A1Methods for acute and long-term treatment of opioid and opioid-like drug addictionDEMERX IB INC·Filed 2023·Application pending·0 cites
- 0881US2024350510A1Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereofDEMERX INC·Filed 2023·Application pending·0 cites
- 0980US7105540B2Cholinesterase inhibitors to treat disorders of attentionEISAI CO LTD·Filed 2002·Granted Sep 12, 2006·16 cites·18 claims
- 1080US2024024336A1Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereofDEMERX INC·Filed 2023·Application pending·0 cites
- 1179US2023346795A1Methods for acute and long-term treatment of alcohol dependence using ibogaine and derivatives thereofDEMERX INC·Filed 2023·Application pending·0 cites
- 1278US6455544B1Use of cholinesterase inhibitors to treat disorders of attentionEISAI CO LTD·Filed 1998·Granted Sep 24, 2002·47 cites·14 claims
- 1373US2022023310A1Methods for acute and long-term treatment of opioid and opioid-like drug addictionDEMERX INC·Filed 2021·Application pending·0 cites
- 1471US5066480AMethod of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonistSQUIBB & SONS INC·Filed 1988·Granted Nov 19, 1991·16 cites·20 claims
- 1570US2021290634A1Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereofDEMERX INC·Filed 2021·Application pending·0 cites
- 1669US9192676B2Oral formulations of mitochondrially-targeted antioxidants and their preparation and useSKULACHEV MAXIM V·Filed 2012·Granted Nov 24, 2015·3 cites·19 claims
- 1769US2021145845A1Methods for acute and long-term treatment of alcohol dependence using ibogaine and derivatives thereofDEMERX INC·Filed 2021·Application pending·0 cites
- 1867US2020078367A1Methods for acute and long-term treatment of opioid and opioid-like drug addictionDEMERX INC·Filed 2017·Application pending·0 cites
- 1965US2020085836A1Methods for acute and long-term treatment of alcohol dependence using ibogaine and derivatives thereofDEMERX INC·Filed 2017·Application pending·0 cites
- 2063US2015231147A1Methods for acute and long-term treatment of drug addictionDEMERX INC·Filed 2014·Application pending·0 cites
- 2162US2019160043A1Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of rem sleep behavior disorderAXOVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
- 2262US2024226001A1Contact Lenses And Other Eye-Contacting Matrices Carrying Mitochondrially-Targeted AntioxidantsMITOTECH S A·Filed 2023·Application pending·0 cites
- 2362US2019151287A1Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative diseaseAXOVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
- 2461US9744174B2Method for noribogaine treatment in patients on methadoneDEMERX INC·Filed 2014·Granted Aug 29, 2017·0 cites·23 claims
- 2560US2015246055A1Methods for acute and long-term treatment of opioid and opioid-like drug addictionDEMERX INC·Filed 2015·Application pending·0 cites
- 2660US2020397754A1Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of rem sleep behavior disorderAXOVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 2758US2015258111A1Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereofDEMERX INC·Filed 2015·Application pending·0 cites
- 2858US2015258110A1Methods for acute and long-term treatment of alcohol dependence using ibogaineDEMERX INC·Filed 2015·Application pending·0 cites
- 2957US2018280406A1Methods for acute and long-term treatment of drug addictionDEMERX INC·Filed 2017·Application pending·0 cites
- 3057US2016271139A1Method for non-toxic treatment for drug withdrawalDEMERX INC·Filed 2014·Application pending·0 cites
- 3157US2021128528A1Use of 5ht2a inverse agonists for treating psychosisAXOVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 3256US9561232B2Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine useDEMERX INC·Filed 2015·Granted Feb 7, 2017·0 cites·22 claims
- 3356US2014288056A1Methods for non-toxic treatment for drug withdrawalFRIEDHOFF LAWRENCE·Filed 2014·Application pending·0 cites
- 3455US2017368073A1Use of ibogaine and derivatives thereof for the treatment of painDEMERX INC·Filed 2017·Application pending·0 cites
- 3554US2017368074A1Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine useDEMERX INC·Filed 2017·Application pending·0 cites
- 3654US2015231146A1Methods for acute and long-term treatment of drug addictionDEMERX INC·Filed 2014·Application pending·0 cites
- 3751US2023038070A1Polymer matrixes for different compositions of mitochondrially targeted antioxidantsMIOTECH S A·Filed 2020·Application pending·0 cites
- 3850US2019046506A1Use of 5ht2a inverse agonists for treating psychosisAXOVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
- 3946US2016324851A1Methods of treating a neurodegenerative diseaseAXOVANT SCIENCES LTD·Filed 2016·Application pending·0 cites
- 4046US2018185276A1Contact lenses carrying mitochonrially-targeted antioxidantsPETROV ANTON DMITRIEVICH·Filed 2016·Application pending·0 cites
- 4146US2002107173A1Method of treating amyloid beta precursor disordersFiled 2002·Application pending·0 cites
- 4244US2019111052A1Methods of treating a neurodegenerative diseaseAXOVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
- 4343US9591978B2Methods and compositions for pre-screening patients for treatment with noribogaineDEMERX INC·Filed 2015·Granted Mar 14, 2017·0 cites·10 claims
- 4442US2005215621A1Method of treating amyloid beta precursor disordersANDRX LABS LLC·Filed 2005·Application pending·0 cites
- 4542US2017246163A1Methods of improving balance, gait or both in patients with neurological diseaseAXOVANT SCIENCES GMBH·Filed 2017·Application pending·0 cites
- 4642US2023181604A1Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory ConditionsMITOTECH S A·Filed 2021·Application pending·0 cites
- 4741US2005215620A1Method of treating amyloid beta precursor disordersANDRX LABS LLC·Filed 2005·Application pending·0 cites
- 4840US2015342959A1Methods and compositions for sustained noribogaine treatmentDEMERX INC·Filed 2015·Application pending·0 cites
- 4940US2015258104A1Use of noribogaine for the treatment of painDEMERX INC·Filed 2015·Application pending·0 cites
- 5040US2015258114A1Methods for acute and long-term treatment of substance abuse using ibogaineDEMERX INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →